FDA Panel Urges Drug Alert An advisory committee recommends the FDA issue stronger warnings about the use of antidepressants called SSRIs in children and teenagers. The panel concludes that available research suggests the drugs can double the incidence of suicidal thoughts and attempts. Hear NPR's Joanne Silberner.
NPR logo

FDA Panel Urges Stronger Antidepressant Warning

  • Download
  • <iframe src="https://www.npr.org/player/embed/3918658/3918659" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
FDA Panel Urges Stronger Antidepressant Warning

FDA Panel Urges Stronger Antidepressant Warning

FDA Panel Urges Stronger Antidepressant Warning

  • Download
  • <iframe src="https://www.npr.org/player/embed/3918658/3918659" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

An advisory committee recommends the FDA issue stronger warnings about the use of antidepressants called SSRIs in children and teenagers. The panel concludes that available research suggests the drugs can double the incidence of suicidal thoughts and attempts. Hear NPR's Joanne Silberner.